Testing in matrico using human primary lung fibrotic dECM derived from IPF lungs yields predictive results by providing the disease-specific environment lacking in other in vitro assays.
Experimental groups: Test compound, Nintedanib, Control
Test compound concentrations: Custom
Time course: 72 hours (end-point)
Ordering
Lead time: 6-8 weeks
Assay components
Human primary lung fibrotic dECM
Human primary lung fibroblasts
Download supporting Human IPF gene expression assay protocols
Testing in matrico using human primary lung fibrotic dECM derived from IPF lungs yields predictive results by providing the disease-specific environment lacking in other in vitro assays.
Experimental groups: Test compound, Nintedanib, Control
